X-linked recessive calculator: carrier mothers, affected sons, and Bayesian updating

Short version. In X-linked recessive (XR) inheritance, the disease allele sits on the X chromosome. Males are hemizygous: a single mutant X allele is sufficient to cause the phenotype because they have no second X to compensate. Females are typically unaffected carriers when heterozygous. A carrier mother partnered with an unaffected father transmits the mutant allele to 50% of her sons (who are then affected) and to 50% of her daughters (who are then carriers). Affected fathers transmit the mutant X to all of their daughters (obligate carriers) and to none of their sons. Observed male-to-male transmission is inconsistent with XR. Bayesian updating reduces a woman's carrier probability when she has multiple unaffected sons.

What "X-linked recessive" means

An X-linked recessive gene lies on the X chromosome. Males have one X and one Y, so a single mutant X allele is unopposed and the male manifests the phenotype. Females have two Xs, and a heterozygous female carries one mutant and one wild-type allele; her wild-type allele typically provides enough function and she is unaffected or only mildly affected. A homozygous female (rare, occurring through consanguinity or through a carrier mother and affected father) is typically affected.

X-inactivation complicates the simple picture. Early in female embryogenesis, one X in each cell is randomly silenced. By chance, a carrier female may have more cells with her wild-type X active (and be clinically unaffected) or more with her mutant X active (and show partial manifestation). Skewed X-inactivation is one reason why carrier females for some XR conditions — notably haemophilia A — can have biochemical or clinical features.

Pedigree hallmarks of XR inheritance

• Predominantly affected males: affected females are rare and imply homozygosity.
• No male-to-male transmission: an affected father cannot transmit the mutant X to his son. This is the most discriminating pedigree feature.
• All daughters of an affected father are obligate carriers: they must inherit his X.
• Carrier mother transmits to 50% of sons (affected) and 50% of daughters (carriers).
• Condition often skips generations: an affected maternal grandfather and affected grandson linked by an unaffected carrier mother is the classic "skipping" pattern.

The absence-of-male-to-male-transmission rule is powerful. A single documented father-to-son transmission of the phenotype effectively excludes XR inheritance (assuming paternity) and points instead to autosomal dominant, autosomal recessive pseudodominance, or Y-linked inheritance.

Core transmission probabilities

The relevant per-pregnancy probabilities for common crosses are:

Bayesian carrier updating

The at-risk relative in most XR counselling is the daughter or other female relative of an obligate carrier or affected male. Her prior carrier probability from the pedigree (1/2 for a daughter of an obligate carrier, 1/4 for the maternal niece of an affected male, and so on) is updated by the observed phenotypic evidence in her own offspring.

The canonical example: a woman whose brother has Duchenne muscular dystrophy has a 1/2 prior probability of being a carrier (assuming her mother is an obligate carrier). She has three unaffected sons. Each unaffected son has probability 1/2 given she is a carrier, and probability 1 (close to, after accounting for the new-mutation rate) given she is a non-carrier. By Bayes' theorem, her posterior carrier probability is approximately (1/2 × 1/8) / (1/2 × 1/8 + 1/2 × 1) = 1/9.

This kind of updating is routine in XR counselling. Each additional unaffected son roughly halves the carrier probability. Molecular testing for a known pathogenic variant collapses the uncertainty further: a targeted carrier test on the at-risk relative, once the familial variant is known, is the highest-yield downstream step.

The new-mutation rate

Several X-linked recessive conditions have substantial de novo mutation contributions. Duchenne muscular dystrophy is the classic case: approximately one-third of cases are attributable to de novo mutations under the Haldane rule for steady-state allele frequency, reflecting the reproductive disadvantage of affected males. This has important counselling implications:

• The mother of an isolated affected male is not automatically an obligate carrier. She may be a carrier who inherited the variant from her own mother (also a carrier), or she may carry a de novo mutation in her germline, or the de novo mutation may have occurred in the proband's own germline.
• Maternal carrier testing is essential to refine sibling recurrence risk. A negative blood test for the maternal carrier reduces but does not eliminate the risk, because of germline mosaicism.
• Empirical recurrence-risk estimates for unverified carrier status mothers of an isolated male DMD proband are non-trivial — typically in the range of several percent — and should be communicated carefully.

Clinical examples

Haemophilia A (F8) and B (F9) are classic XR bleeding disorders. Carrier females have reduced but usually sufficient factor levels; they are typically unaffected but can show bleeding phenotypes in situations of stress (surgery, childbirth) or with significantly skewed X-inactivation. Factor level testing in carriers provides a biochemical assay complementary to molecular testing.

Duchenne muscular dystrophy (DMD) and the allelic Becker muscular dystrophy are XR myopathies of varying severity. Creatine kinase is a cheap and sensitive marker in affected boys; female carriers can have elevated CK but this is not a reliable discriminator. Molecular deletion/duplication and sequencing analysis is the standard for carrier confirmation.

G6PD deficiency is a common XR enzyme deficiency that can cause haemolytic episodes triggered by specific drugs or foods. Its high allele frequency in several populations means carrier mother-affected son crosses are relatively common, and affected (homozygous) females are seen more often than for rarer XR conditions.

Red-green colour blindness caused by X-linked OPN1LW or OPN1MW variants is a benign XR condition. It illustrates textbook XR inheritance at high allele frequency, with carrier females occasionally showing subtle colour-discrimination differences.

Common pitfalls

• Assuming the mother of an isolated affected male is a definite carrier without considering de novo mutation.
• Over-interpreting carrier phenotype variability as non-carrier status — X-inactivation means some carriers manifest mild features, and some do not.
• Confusing X-linked recessive with X-linked dominant inheritance, in which heterozygous females are typically affected (for example, fragile X with full mutation in females, though fragile X has additional complexity).
• Forgetting that an affected father's daughters are all obligate carriers (100%), not 50%.
• Under-counting generational skipping when small sibships obscure the carrier-mother-to-affected-grandson pattern.

How Evagene supports this

Evagene's Mendelian inheritance calculator includes an X-linked recessive model that applies the per-cross transmission probabilities above, flags obligate carrier females (daughters of affected fathers, mothers of affected sons in multiplex families), and performs Bayesian carrier updating as unaffected sons are added to the pedigree. The absence-of-male-to-male-transmission rule is automatically checked: a pedigree with a documented father-to-son transmission will not be classified as X-linked recessive even if other features are suggestive.

For conditions with a non-trivial de novo mutation rate, the calculator distinguishes between the "mother is certainly a carrier" and "mother may carry a de novo event" scenarios and reports both. When molecular testing results are recorded, the calculator conditions on them and tightens the carrier-probability bounds accordingly.

As with all Mendelian analysis, the pedigree is the source of truth and the calculator is transparent about which relatives drive which numbers. AI-assisted interpretation, using your own LLM key, drafts a structured summary that names the obligate carriers, the at-risk carriers, and the Bayesian-updated posterior probabilities — as a drafting aid for the clinician's final report.

Frequently asked questions

Related reading

• Mendelian inheritance calculator overview
• Autosomal dominant calculator
• Autosomal recessive calculator
• Carrier probability calculator
• Identifying inheritance patterns
• Clinical genetics pedigree tools